1James, PT, Rigby, N & Leach, R (2004) International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11, 3–8.
2Adams, KF, Schatzkin, A, Harris, TB, et al. (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355, 763–778.
3Lakka, TA, Lakka, HM, Salonen, R, et al. (2001) Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 154, 497–504.
4Kenchaiah, S, Evans, JC, Levy, D, et al. (2002) Obesity and the risk of heart failure. N Engl J Med 347, 305–313.
5Vincent, HK & Taylor, AG (2006) Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 30, 400–418.
6Van Gaal, LF, Vertommen, J & De Leeuw, IH (1998) The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 137, 39–44.
7Giudice, A, Arra, C & Turco, MC (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 647, 37–74.
8Thornalley, PJ & Rabbani, N (2012) Dietary and synthetic activators of the antistress gene response in treatment of renal disease. J Ren Nutr 22, 195–202.
9Scalbert, A, Manach, C, Morand, C, et al. (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45, 287–306.
10Sinha, K, Chaudhary, G & Gupta, YK (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71, 655–665.
11King, RE, Bomser, JA & Min, DB (2006) Bioactivity of resveratrol. Comp Res Food Sci Food Safety 5, 65–70.
12López-Vélez, M, Martínez-Martínez, F & Valle-Ribes, C (2003) The study of phenolic compounds as natural antioxidants in wine. Crit Rev Food Sci Nutr 43, 233–244.
13Sharma, M & Gupta, YK (2002) Chronic treatment with trans-resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71, 2489–2498.
14Shigematsu, S, Ishida, S & Hara, M (2003) Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 34, 810–817.
15Salem, N, Kim, HY & Yergey, JA (1985) Health effects of polyunsaturated fatty acids in sea foods. In Docosahexaenoic Acid: Membrane Function and Metabolism, pp. 263–317 [Simopoulos, AP, Kifer, RR and Martin, RE, editors]. Orlando: Academic Press.
16Siddiqui, RA, Harvey, KA & Zaloga, GP (2008) Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 19, 417–437.
17Garrel, C, Ceballos-Picot, I, Germain, G, et al. (2007) Oxidative stress-inducible antioxidant adaptive response during prostaglandin F2alpha-induced luteal cell death in vivo. Free Radic Res 41, 251–259.
18Zerouga, M, Stillwell, W, Stone, J, et al. (1996) Phospholipid class as a determinant in docosahexaenoic acid's effect on tumor cell viability. Anticancer Res 16, 2863–2868.
19Stillwell, W, Jenski, LJ, Crump, FT, et al. (1997) Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids 32, 497–506.
20El-Mowafy, AM, Abdel-Dayem, MA, Abdel-Aziz, A, et al. (2011) Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility. Biochim Biophys Acta 1811, 460–467.
21Iraz, M, Erdogan, H, Ozyurt, B, et al. (2005) Omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats. Ann Clin Lab Sci 35, 169–173.
22Poderoso, JJ, Carreras, MC, Lisdero, C, et al. (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328, 85–92.
23Drapper, HH & Hadley, M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186, 421–431.
24Levine, RL, Garland, D, Oliver, CN, et al. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464–478.
25Aebi, H (1984) Catalase in vitro. Methods Enzymol 105, 121–126.
26Bannister, JV & Calabrese, L (1987) Assays for superoxide dismutase. Methods Biochem Anal 32, 279–312.
27Flohé, L & Günzler, WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105, 114–121.
28Frederico, MJ, Justo, SL, Da Luz, G, et al. (2009) Exercise training provides cardioprotection via a reduction in reactive oxygen species in rats submitted to myocardial infarction induced by isoproterenol. Free Radic Res 43, 957–964.
29Rosengren, A, Wedel, H & Wilhelmsen, L (1999) Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20, 269–277.
30Ross, SJ, Poehlman, ET, Johnson, RK, et al. (1997) Body fat distribution predicts cardiac risk factors in older female coronary patients. J Cardiopulm Rehabil 17, 419–427.
31Lakka, HM, Lakka, TA, Tuomilehto, J, et al. (2002) Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23, 706–713.
32Duflou, J, Virmani, R, Robin, I, et al. (1995) Sudden death as a result of heart disease in morbid obesity. Am J Heart 130, 306–313.
33Nakazono, K, Watanabe, N, Matsuno, K, et al. (1991) Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88, 10045–10048.
34Furukawa, S, Fujita, T, Shimabukuro, M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761.
35Keaney, JF, Larson, MG, Vasan, RS, et al. (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23, 434–439.
36Zhang, H, Zhang, J, Ungvari, Z, et al. (2009) Resveratrol improves endothelial function role of TNF alpha and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29, 1164–1171.
37Gaiva, MH, Couto, RC, Oyama, LM, et al. (2001) Polyunsaturated fatty acid-rich diets: effect on adipose tissue metabolism in rats. Br J Nutr 86, 371–377.
38Ozata, M, Mergen, M, Oktenli, C, et al. (2002) Increased oxidative stress and hypozincemia in male obesity. Clin Biochem 35, 627–631.
39Leonard, SS, Xia, C, Jiang, BH, et al. (2003) Resveratrol scavenges reactive oxygen species and effects radical induced cellular responses. Biochem Biophys Res Commun 309, 1017–1026.
40Robb, EL, Page, MM, Wiens, BE, et al. (2008) Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem Biophys Res Commun 367, 406–412.
41Spanier, G, Xu, H, Xia, N, et al. (2009) Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathioneperoxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60, 111–116.
42McLennan, PL & Abeywardena, MY (2005) Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Membr Biol 206, 85–102.
43Barletta, MA, Lehr, D, Guideri, G, et al. (1978) Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats. J Pharm Sci 67, 1390–1394.
44Gudbjarnason, S (1989) Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med 731, 117–128.
45Barbosa, DS, Cecchini, R, El Kadri, MZ, et al. (2003) Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19, 837–842.
46Ashrafian, H, Czibik, G, Bellahcene, M, et al. (2012) Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 15, 361–371.
47Chen, CY, Jang, JH, Li, MH, et al. (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331, 993–1000.
48Hsieh, TC, Lu, X, Wang, Z, et al. (2006) Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem Res 2, 275–285.
49Omata, Y, Saito, Y, Fujita, K, et al. (2008) Induction of adaptive response and enhancement of PC12 cells tolerance by lipopolysaccharide primarily through the upregulation of glutathione S-transferase A3 via Nrf2 activation. Free Radic Biol Med 45, 1437–1445.
50Rubiolo, JA, Mithieux, G, Vega, FV, et al. (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591, 66–72.
51Anderson, EJ, Thayne, K, Harris, M, et al. (2012) Aldehyde stress and up-regulation of Nrf2-mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n-3 polyunsaturated fatty acids. Biochem J 441, 359–366.
52Ishikado, A, Nishio, Y, Morino, K, et al. (2010) Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem Biophys Res Commun 402, 99–104.
53Mori, TA & Beilin, LJ (2004) Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6, 461–467.
54Tsai, SH, Lin-Shiau, SY & Lin, JK (1999) Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 126, 673–680.
55Manna, SK, Mukhopadhyay, A & Aggarwal, BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509–6519.
56Rodrigo, R, Prieto, JC & Castillo, R (2013) Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications. Clin Sci (Lond) 124, 1–15.
57Pallarès, V, Calay, D, Cedó, L, et al. (2012) Enhanced anti-inflammatory effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7 macrophages. Br J Nutr 108, 1562–1573.
58Kaneko, H, Anzai, T, Morisawa, M, et al. (2011) Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis 217, 350–357.
59Zang, QS, Sadek, H, Maass, DL, et al. (2012) Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model. Am J Physiol Heart Circ Physiol 302, H1847–H1859.